Holen Sie sich die Stockscreener-App
1.37
1.44%
-0.02
Handel nachbörslich:
1.37
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Decliners Report: Whats the MACD signal for Lucid Diagnostics Inc2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Lucid Diagnostics CEO to detail growth strategy in March 26 call - Stock Titan
Price Action: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Risk Recap: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Breakouts Watch: Can Lucid Diagnostics Inc expand into new marketsVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
LUCD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to “Hold” at Wall Street Zen - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to "Hold" at Wall Street Zen - MarketBeat
LUCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Downgrade Watch: Is Lucid Diagnostics Inc likely to announce a buybackDay Trade & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Lucid Diagnostics CEO granted 2.17M restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) receives 123,000-share restricted stock grant - Stock Titan
123K-share equity grant to Lucid Diagnostics (LUCD) director Debra White vests 2029 - Stock Titan
Lucid director granted 123,000 restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) awarded 123,000 restricted shares - Stock Titan
Director at Lucid Diagnostics (LUCD) granted 123K restricted shares - Stock Titan
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity - Stock Titan
Director at Lucid Diagnostics (NASDAQ: LUCD) receives 123,000-share restricted stock grant - Stock Titan
Lucid Diagnostics (LUCD) CFO granted 470,000 restricted shares vesting in 2029 - Stock Titan
Lucid Diagnostics (LUCD) COO awarded 620,000 restricted shares in Form 4 filing - Stock Titan
Lucid Diagnostics (LUCD) awards 300,000 restricted shares to General Counsel - Stock Titan
Aberdeen Group plc Invests $2.53 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Aug Decliners: Is Lucid Diagnostics Inc likely to announce a buybackJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
Retail Surge: Can Lucid Diagnostics Inc expand into new markets2025 Institutional Moves & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Summary: Can Lucid Diagnostics Inc expand into new marketsMarket Growth Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Lucid Diagnostics Inc. (LUCD) stock: slides after early spike despite major VA contract win - parameter.io
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):